FDA warns Novo Nordisk of potential unreported GLP-1 side effects

FDA warns Novo Nordisk of potential unreported GLP-1 side effects

The FDA issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster medications.

The Food and Drug Administration issued a warning letter to Novo Nordisk the maker of Ozempic and Wegovy for failing to report potential side effects in patients who took its blockbuster medications.… [+1380 chars]